Creating breakthrough medicines that change patients’ lives starts with a commitment to identify the health challenges of the future and advance emerging science. As an independent and family- owned company, we have the freedom to pursue our long- term vision, with distinctive approaches that enable new journeys of discovery today that will transform the lives of patients in generations to come.
Investing in our people: University of Medicine Excellence
As of December 2022, almost one thousand of our employees have graduated from a program developed together with Harvard Medical School’s Executive Education
Reimagining digital healthcare worldwide
How our digital lab BI X innovates in Ingelheim and Shanghai
Combating complex diseases with data
How Dataland creates disrupting insights for our company
Boehringer Ingelheim Venture Fund
Find out more about how our Venture Fund team drives innovation through strategic investments in early-stage science and technology.
Explore our molecules on opnMe.com
With opnMe, we share best-in-class molecules with the scientific community. Order free of charge or collaborate with us to unlock their full potential.